JCR Pharmaceuticals Co.,Ltd.JP:4552

Market cap
¥82.5B
P/E ratio
15.3x
Mar 31,
2013
Mar 31,
2014
Mar 31,
2015
Mar 31,
2016
Mar 31,
2017
Mar 31,
2018
Mar 31,
2019
Mar 31,
2020
Mar 31,
2021
Mar 31,
2022
Mar 31,
2023
Net sales14,10015,70616,85617,43818,08520,59423,16024,78130,08551,08234,343
Cost of sales5,0375,8425,7416,4595,7326,1286,5677,9017,81210,4618,886
Gross profit (loss)9,0639,86411,11510,97912,35314,46516,59216,88022,27240,62025,456
Selling, general and administrative expenses7,9128,3189,1008,8269,99110,68111,62513,63514,00320,68620,480
Operating profit (loss)1,1511,5452,0152,1532,3623,7844,9673,2448,26919,9334,975
Interest income36343127172020197733
Dividend income1921242321252525252828
Foreign exchange gains4557551247-398206551387
Dividend income1921242321252525252828
Other243812226133212328656891
Foreign exchange gains4557551247-398206551387
Non-operating income13924140334823610514881305656541
Other243812226133212328656891
Non-operating income13924140334823610514881305656541
Interest expenses5044383329272122424544
Commission expenses--------111215
Loss on abandonment of inventories----------20
Other15124025351179311818
Non-operating expenses133106785864464732857799
Ordinary profit (loss)1,1561,6812,3402,4432,5343,8435,0683,2938,48820,5125,418
Gain on sale of investment securities-119--------10
Extraordinary income-154-16217782131170-10
Loss on disposal of non-current assets2120603253725216
Loss on cancellation of contracts---------1,000-
Other32----2--105-
Extraordinary losses91157606225221251,10816
Profit (loss) before income taxes1,0651,6772,3342,4592,4933,8954,9283,4228,65319,4045,412
Income taxes - current4486733718523949641,1691,0172,8365,549525
Income taxes - deferred-114-292281-182236-13948-274-1,072-6631,099
Income taxes3343816526706308251,2177421,7644,8861,625
Profit (loss)--1,6821,7901,8633,0693,7102,6796,88814,5173,787
Profit (loss) attributable to non-controlling interests--000--41-41014
Profit (loss) attributable to owners of parent--1,6821,7891,8633,0703,7152,6786,89214,5073,772